Intratumoral Delivery of Tavokinogene Telseplasmid Yields Systemic Immune Responses in Metastatic Melanoma Patients

Annals of Oncology - United Kingdom
doi 10.1016/j.annonc.2019.12.008
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Intratumoral Injection of Propionibacterium Acnes Suppresses Malignant Melanoma by Enhancing Th1 Immune Responses

PLoS ONE
Multidisciplinary
2011English

Digital Immunohistochemistry Analysis of Intratumoral Immune Infiltrates in Prostate Cancer Patients Treated With Intraprostatic/Systemic PSA-TRICOM Vaccine

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2013English

Molecular Insights on the Peripheral and Intratumoral Effects of Systemic High-Dose rIL-2 (Aldesleukin) Administration for the Treatment of Metastatic Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2011English

Impact of Clinicopathological Characteristics on Survival in Patients Treated With Immune Checkpoint Inhibitors for Metastatic Melanoma

International Journal of Cancer
Cancer ResearchOncology
2018English

Immune Checkpoint Inhibitors Therapy in Older Patients (≥ 70 Years) With Metastatic Melanoma: A Multicentre Study

Postepy Dermatologii I Alergologii
DermatologyAllergyImmunology
2019English

Bevacizumab Plus Ipilimumab in Patients With Metastatic Melanoma

Cancer immunology research
Cancer ResearchImmunology
2014English

Intratumoral G100, a TLR4 Agonist, Induces Anti-Tumor Immune Responses and Tumor Regression in Patients With Merkel Cell Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2018English

Analysis of DNA Methylation Patterns in the Tumor Immune Microenvironment of Metastatic Melanoma

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2020English

Is There a Role for Immune Checkpoint Blockade in Metastatic Uveal Melanoma?

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy